US Broker Ratings

Revvity, Inc. (RVTY) Stock Analysis: Unpacking a 27% Potential Upside in Healthcare Diagnostics

Revvity, Inc. (NYSE: RVTY), a stalwart in the healthcare diagnostics and research industry, presents a compelling opportunity for investors seeking exposure to the life sciences sector...

Molina Healthcare Inc (MOH) Stock Analysis: Exploring a 21% Potential Upside for Investors

Molina Healthcare Inc (NYSE: MOH), a prominent player in the healthcare plans sector, is making waves in the investment community with its robust growth metrics and..

Cencora, Inc. (COR) Stock Analysis: Exploring a Robust 7.37% Potential Upside in the Healthcare Sector

Cencora, Inc. (NYSE: COR), a prominent player in the healthcare sector, has been making waves in the medical distribution industry. With a solid market cap of..

Alcon Inc. (ALC) Stock Analysis: Unveiling a 20.48% Upside Potential for Investors

Alcon Inc. (NYSE: ALC), a leader in the global eye care industry, is making waves in the healthcare sector with its robust portfolio of innovative products..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: A 17% Potential Upside Beckons Investors

GE HealthCare Technologies Inc. (NYSE: GEHC) stands as a formidable player within the healthcare sector, specifically focusing on health information services. With a market capitalization of..

Illumina, Inc. (ILMN) Stock Analysis: Unveiling a 14.87% Potential Upside Amidst Market Challenges

Illumina, Inc. (NASDAQ: ILMN), a leader in the healthcare sector, is renowned for its cutting-edge genomic and genetic sequencing solutions. Headquartered in San Diego, California, Illumina..

Insulet Corporation (PODD) Stock Analysis: A Look at its Robust Revenue Growth and Analyst Optimism

Insulet Corporation (NASDAQ: PODD), a pioneer in the medical devices sector, is making waves with its innovative insulin delivery systems. As a leader in healthcare technology,..

argenx SE (ARGX) Stock Analysis: Unveiling a 38.75% Potential Upside Fueled by Breakthrough Biotech Innovations

argenx SE (NASDAQ: ARGX), a pioneering name in the biotechnology sector, is capturing the attention of investors with its robust growth trajectory and promising drug pipeline...

Koninklijke Philips N.V. (PHG) Investor Outlook: Exploring a 31.59% Upside Potential in the Healthcare Sector

As an integral player in the healthcare sector, Koninklijke Philips N.V. (NYSE: PHG) has piqued investor interest with its robust presence in the medical devices industry...

Encompass Health Corporation (EHC) Stock Analysis: A Lucrative Healthcare Play with Solid Growth Prospects

Encompass Health Corporation (NYSE: EHC), a prominent player in the healthcare sector, presents a compelling opportunity for investors looking to tap into the medical care facilities..

Stryker Corporation (SYK) Stock Analysis: Exploring a 7% Upside in the Medical Devices Sector

Stryker Corporation (NYSE: SYK), a leading player in the healthcare sector, is catching the eye of investors with its robust market presence and growth potential. Operating..

Alnylam Pharmaceuticals (ALNY) Stock Analysis: A Biotech Giant with a $42 Billion Market Cap and Promising Pipeline

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a pioneering force in the biotechnology sector, has carved a niche for itself through its groundbreaking work in ribonucleic acid interference..

Waters Corporation (WAT) Stock Analysis: A 10.32% Potential Upside with Strong Analyst Confidence

Waters Corporation (NYSE: WAT), a prominent player in the healthcare sector, particularly in the diagnostics and research industry, is capturing investor attention with a market capitalization..

Astrazeneca PLC (AZN)

⚠️ No article content returned.

..

Medtronic plc (MDT): Investor Outlook and Potential 11.71% Upside in the Healthcare Sector

Medtronic plc (MDT), a global leader in the medical devices industry, offers a compelling investment opportunity with a potential upside of 11.71%, according to analyst ratings...

Sanofi (SNY)

⚠️ No article content returned.

..

Royalty Pharma plc (RPRX) Stock Analysis: A Promising 15.76% Potential Upside for Investors

Royalty Pharma plc (NASDAQ: RPRX), a leader in the biotechnology sector, is capturing investor attention with a notable potential upside of 15.76%. With a market capitalization..

Novartis AG (NVS) Stock Analysis: Evaluating the 12.4% Revenue Growth Amidst Market Challenges

Novartis AG (NYSE: NVS), a Swiss pharmaceutical titan, continues to capture investor attention with its robust performance in the healthcare sector, particularly within the drug manufacturing..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Exploring a Promising 12.64% Upside in the Biotech Sector

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a significant player in the biotechnology sector, primarily known for its groundbreaking work in treating cystic fibrosis (CF). With..

HCA Healthcare, Inc. (HCA) Stock Analysis: Exploring Growth Potential with Impressive ROE and Analyst Ratings

HCA Healthcare, Inc. (HCA), a prominent player in the medical care facilities industry, stands as a compelling opportunity for investors seeking exposure in the healthcare sector...

US Broker Ratings

US Broker Ratings

FTSE 100

Funds